Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups
Patents for C07C 271 - Derivatives of carbamic acid, i.e. compounds containing any of the groups the nitrogen atom not being part of nitro or nitroso groups (15,621)
11/2000
11/21/2000US6150344 Useful for treatment of diseases such as malaria and alzheimer's disease; compounds are attached to a solid support
11/21/2000US6150304 2-aryl-cyclopentane-1,3-dione derivatives
11/16/2000WO2000035998B1 Association of compounds in carbon dioxide and the gels and/or foams formed therefrom
11/16/2000WO2000028822A3 Herbicidal 3-(benzo(ox/thi)azol-7-yl)-1h-pyrimidine-2,4-diones
11/15/2000EP1052250A1 Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
11/15/2000EP1051397A1 Method for preparing an n- (aliphatic or aromatic)carbonyl]-2-aminoacetamide compound and a cyclyzed compound
11/15/2000EP1051143A2 Oxidizing hair coloring agents containing 2,5-diamino-1-phenylbenzene derivatives and novel 2,5-diamino-1-phenylbenzene derivatives
11/14/2000US6147254 Reacting chiral base in solution with enantiomeric mixture of n-protected-cis-4-amino-2-cyclopentene-1-carboxylic acids to produce, in diastereoselective manner by fractional crystallisation, substantially pure salt
11/14/2000US6147253 N-protected/N-substituted-beta-amino-hydroxy sulfonates
11/14/2000US6147210 Practical synthesis of benzoxazinones useful as HIV reverse transcriptase inhibitors
11/14/2000US6147063 Therapeutic substituted guanidines
11/14/2000CA2018665C Adhesion promoters
11/09/2000WO2000066524A1 D-mannitol derivatives as hiv aspartyl protease inhibitors
11/09/2000WO2000066522A1 Glucocorticoid receptor modulators
11/09/2000WO2000066104A2 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372672A1 D-mannitol derivatives as hiv aspartyl protease inhibitors
11/09/2000CA2372387A1 Ace-2 inhibiting compounds and methods of use thereof
11/09/2000CA2372173A1 Glucocorticoid receptor modulators
11/08/2000EP1049662A1 Inhibitors of alpha4 mediated cell adhesion
11/07/2000US6143919 Polymerizable acidic compounds and methods of preparation
11/07/2000US6143729 Compounds related to the amidinium family, pharmaceutical compositions containing same, and uses thereof
11/07/2000CA2156455C Glycinamide derivatives, processes for their preparation and medicines containing them
11/07/2000CA1341136C Arylalkyl-amines and -amides having anticonvulsant and neuroprotective properties
11/02/2000WO2000064865A1 Monomers and oligourea peptidomimetics and process for the prepa ration thereof
11/02/2000WO2000064864A1 N-protected amines and their use as prodrugs
11/02/2000WO2000064863A1 Use of 2,4-diamino-3-hydroxycarboxylic acid derivatives as proteasome inhibitors
11/02/2000EP1048647A1 N-Chlorocarbonyl-carbamate derivative and its use in the preparation of arthropodicidal oxadiazines
11/02/2000CA2368205A1 N-protected amines and their use as prodrugs
11/01/2000CN1271724A (2-substituted oxyphenyl) alkane acylamide derivative and hair nourishing agent, skin external use agent
11/01/2000CN1057995C Substituted ortho-ethenylphenylacetic acid derivatives
10/2000
10/31/2000US6140532 O-carbamoyl-phenylalaninol having substituent at benzene ring, its pharmaceutically useful salts and method for preparing the same
10/31/2000US6140531 Heating 2-alkenyl azide in solvent
10/31/2000US6140530 Quinidine conjugates and their use in immunoassays
10/31/2000US6140361 For inhibiting binding of human immunodeficiency virus rev protein to rev responsive elements (rre)
10/31/2000US6140353 Used as medicaments for the treatment and/or prevention of thromboses, apoplexy, cardiac infarction, inflammation and arteriosclerosis or as antitumor agents
10/26/2000WO2000063166A1 Carbamic acid derivatives and their use as metabotropic glutamate receptor ligands
10/26/2000WO2000063157A1 Disubstituted benzene derivatives
10/26/2000WO2000020357A3 Chemical constructs
10/26/2000DE19917961A1 Verfahren zur Herstellung von Aminosäurederivaten Process for the preparation of amino acid derivatives
10/25/2000EP1046638A2 Process for the preparation of aminoacid derivatives
10/25/2000EP1046627A2 Enantiopure reagents and process for the separation of enantiomers
10/25/2000EP1045832A2 Novel urethanes, thio and dithio analogues, the salts thereof, medicaments containing said compounds, use and method for the production thereof
10/25/2000EP1045829A1 Method for producing n-(3-amino-4-fluorophenyl)- sulphonamides, n-(3-amino-4-fluorophenyl) carboxylic acid amides and n-(3-amino-4-fluorophenyl) carbamates
10/25/2000EP1005450A4 Method of utilizing isocyanate linkages for forming multi-tier cascade polymers
10/25/2000CN1057755C Fluoroalkenyl compounds and preparing method
10/24/2000US6137007 Enantiomer compositions of (1R,4S)-1-butyrylamino-4-(hydroxymethyl)-2-cyclopentene
10/24/2000US6137002 Glycoprotein IIb/IIIa antagonists
10/24/2000US6136999 Chemical intermediate useful in synthesis of paclitaxel
10/24/2000US6136787 Interleukin 1β protease and interleukin 1β protease inhibitors
10/21/2000CA2305944A1 Process for separating enantiomers and enantiopur reagent
10/19/2000WO2000061545A1 Methods for solid phase combinatorial synthesis of integrin inhibitors
10/19/2000WO2000061542A1 Caspase inhibitors and the use thereof
10/19/2000WO2000061541A2 Pharmaceutical compounds
10/19/2000WO2000035998A3 Association of compounds in carbon dioxide and the gels and/or foams formed therefrom
10/19/2000CA2370425A1 Pharmaceutical compounds
10/19/2000CA2369619A1 Caspase inhibitors and the use thereof
10/18/2000EP0493606B1 Heterocycle-substituted benzene derivative, production thereof, and herbicide containing the same as active ingredient
10/18/2000CN1057522C Naphthalene derivs. as prostaglandin I2 agonists
10/17/2000US6133473 Free of by-products; prepared by reacting an isocyanate with a hydroxylated compound or oxime in the presence of certain catalysts
10/17/2000US6133457 Process for preparing pharmaceutical compounds
10/17/2000US6133409 Reacting a solid support-bound n-alkylated hydroxamic acid with a carbon-nitrogen cleaving organometallic compund to liberate the product ketone
10/12/2000WO2000059865A1 4-aminobutanoic acid derivatives and drugs containing these derivatives as the active ingredient
10/11/2000EP1043351A2 Urethane groups containing (meth)acrylic acid esters, process for their preparation and their use as well as radiation-curable coatings containing them
10/11/2000EP1043309A1 Process for synthesizing para-and/or meta-substituted cyanophenylalanine derivatives
10/11/2000EP1042277A1 Naphthalene derivatives
10/11/2000EP1041995A1 Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
10/11/2000CN1269136A Fluoric alkenyl compound and use as insect repellent agent
10/11/2000CN1057292C Dicyclic compound, medicinal composition containing same and use thereof
10/10/2000US6130353 Chromatography on chiral polysaccharide stationary phase; eluting with mobile phase in liquid lower alkanol, oil soluble carboxylic acid
10/10/2000US6130315 Substrates in which the scissile amide bond has been replaced by an activated electrophilic ketone moiety; antiinflammatory agents; antiproliferative/anticarcinogenic/antiarthritic agents; treatment of autoimmune diseases
10/10/2000US6130247 Phenylcarbamates, methods for preparing them and agents containing them
10/10/2000US6130225 Substituted p-trifluoromethylphenyluracils
10/09/2000CA2304420A1 Novel process for synthesizing para-and/or meta-substituted cyanophenylalanine derivatives
10/05/2000DE19915070A1 Urethangruppenhaltige (Meth)acrylsäureester, deren Herstellung und Verwendung sowie diese umfassende strahlungshärtbare Überzugsmassen Containing urethane (meth) acrylic acid esters, their preparation and use, and comprehensive radiation curable coating compositions
10/04/2000EP1041064A2 N-substituted alpha aminoacid amides as calcium channel modulators
10/04/2000EP1040119A2 Hemiasterlin analogs
10/04/2000EP1040095A1 Cyclohexene carboxylates as neuraminidase inhibitors
10/04/2000EP1040094A1 Substituted cyclopentane and cyclopentene compounds useful as neuraminidase inhibitors
10/04/2000EP1039902A2 Inhibitors of gap junction communication
10/03/2000US6127412 Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
10/03/2000US6127191 Solid support having plurality of pendant scaffold moieties covalently attached; for synthesis of bioactive molecules
10/03/2000US6127170 Multifunctional complexes for gene transfer into cells comprising a nucleic acid bound to a polyamine and having a endosome disruption agent
10/03/2000CA2000342C Novel peptidase inhibitors
09/2000
09/28/2000WO2000056760A1 Phenylalanine derivatives
09/28/2000WO2000056721A1 Solid phase synthesis of benzodiazepine diones
09/28/2000WO2000056702A1 Resorcinol derivatives
09/28/2000WO2000056285A1 Urethane surfactants and their use in personal care formulations
09/28/2000WO2000025767A3 Use of triphenylbutene derivatives for the treatment of neurological disorders
09/28/2000CA2855415A1 Phenylalanine derivatives
09/28/2000CA2368733A1 Phenylalanine derivatives
09/28/2000CA2364612A1 Urethane surfactants and their use in personal care formulations
09/27/2000EP1038864A1 Novel metalloproteinase inhibitors
09/27/2000EP1038863A2 Substituted dimeric compounds, process for their preparation and pharmaceutical compositions thereof
09/27/2000EP1037905A1 Antipicornaviral compounds and methods for their use and preparation
09/27/2000EP1037904A2 Branched building units for synthesizing cyclic peptides
09/27/2000EP1037865A1 Synthesis of cc-1065/duocarmycin analogs
09/27/2000EP0885188B1 Hydroxyamidino derivatives useful as nitric oxide synthase inhibitors
09/27/2000CN1268117A Novel inhibitors of aggrecanase and matrix metalloproteinases for the treatment of arthritis
09/26/2000US6124471 Phenyldiboronic acid reagents and complexes
09/26/2000US6124345 Carbamoyl carboxylic acid amide oximes
1 ... 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 ... 157